Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells-Reference-Cited by-同舟云学术

Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells

Published:2023-09-29 Issue:5 Volume:50 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Kanemaru Ayumi¹,Ito Yuki¹,Yamaoka Michiko¹,Shirakawa Yuki²,Yonemaru Kou¹,Miyake Shunsuke¹,Ando Misaki¹,Ota Masako¹,Masuda Takeshi³,Mukasa Akitake⁴,Li Jian-Dong⁵,Saito Hideyuki¹,Hide Takuichiro⁶,Jono Hirofumi¹

Affiliation:

1. Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860‑8556, Japan

2. Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo 113‑8421, Japan

3. Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 862‑0973, Japan

4. Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860‑8556, Japan

5. Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA

6. Department of Neurosurgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252‑0375, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference54 articles.

1. Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border;Hide;EBioMedicine,2018

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. The Translocator Protein (TSPO) genetic polymorphism A147T is associated with worse survival in male glioblastoma patients;Troike;Cancers (Basel),2021

4. Advances in brain tumor surgery for glioblastoma in adults;Lara-Velazquez;Brain Sci,2017

5. Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma;De Barros;J Neurooncol,2019